Suraksha Diagnostics

What Suraksha Diagnostics does

Suraksha Diagnostic Limited is a publicly listed Indian diagnostic services company headquartered in Kolkata, founded in 1992. It operates 70+ diagnostic centres across West Bengal, Bihar, and Assam, delivering integrated pathology, radiology, genomics, and specialist polyclinic services to individual consumers, government hospital Public-Private Partnerships (PPPs), and corporate clients. The company employs between 1,001 and 5,000 staff and reported FY26 (year ended March 2026) consolidated revenue of Rs 310.41 crore, up 23.13% year-over-year.

The service catalogue spans over 2,000 diagnostic tests. Pathology covers microbiology, serology, molecular biology, histopathology, haematology, clinical biochemistry, immunohistochemistry, FISH, cytogenetics, flow cytometry, newborn screening (LC-MS/MS), and Next Generation Sequencing (NGS). Radiology includes X-ray, AI-enabled MRI, 128-slice cardiac CT, 4D ultrasound, DEXA, mammography, and OPG. Genomics includes Non-Invasive Prenatal Testing (NIPT), microarray, QF-PCR, FISH, and karyotyping. The technology stack relies on equipment from Siemens Healthineers, Wipro GE Healthcare, Roche Diagnostics India, HORIBA, and Samsung, augmented by AI-driven radiography for disease detection, real-time report prioritization, and mammography-based cancer detection. The Suraksha Reference Lab holds NABL (ISO 15189) and CAP accreditation. Distribution combines owned centres, franchise-operated sites, five government hospital PPPs, home sample collection, and online consultation, with revenue generated via per-test fees, bundled health packages (Rs 2,500-Rs 9,500), and consultation fees (Rs 500-Rs 1,500).

Suraksha's revenue model is fundamentally a high-volume, unit-priced B2C diagnostic services business with supplementary enterprise and government exposure. In April 2026, the company acquired a 63% stake in Fetomat Wellness for Rs 5.19 crore to enter the maternal-fetal and reproductive genomics vertical, and it has forged scientific partnerships with Yourgene Health and Thermo Fisher Scientific to support its genetics build-out. Strategic risks include margin compression (FY26 net profit grew only 1.16% YoY despite 23%+ revenue growth), the upcoming departure of Group CFO K S Ravindra by May 31, 2026, and execution risk on multi-state expansion outside the West Bengal core.

Name

Suraksha Diagnostics

Legal name

Suraksha Diagnostic Limited

Website

https://surakshanet.com

Company type

Public

Founded year

1992

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Suraksha Diagnostics is a publicly listed eastern India diagnostic chain operating 70+ centres across West Bengal, Bihar, and Assam, offering 2,000+ pathology, radiology, and genomics tests to individual consumers, government hospital PPPs, and corporate clients.

Ownership category

akta.pro rank

Product category

Diagnostic Healthcare Services

NAICS

Medical and Diagnostic Laboratories (6215), Diagnostic Imaging Centers (621512)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro industry

PRIMARYHLACAGAA

Diagnostic & Triage Decision Support

Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools

SECONDARYHLAGAEAD

Genomics & Molecular Diagnostics (Trial Support)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

• Diagnostic services
• Pathology testing
• Radiology imaging
• Genomic testing
• Health checkup packages

Headquarters

HQ city

Kolkata

HQ country

India

HQ region

Asia

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Diagnostic Testing Services: Pathology tests (over 2000 tests including blood tests, biochemistry, immunology, haematology, microbiology, molecular biology) and radiology services (X-Ray, MRI, CT Scan, Ultrasound, Mammography, DEXA Scan) provided at diagnostic centres. Revenue generated through per-test fees based on individual tests or bundled panels.
2. Health Packages: Pre-defined health checkup packages targeting specific demographics (Men, Women, Senior Citizens, Diabetes, Heart Health, etc.) and conditions. Packages range from basic screenings to comprehensive health assessments, providing predictable revenue through bundled pricing.
3. Medical Consultation Services: Suraksha Polyclinics offering specialist doctor consultations across multiple specialties. Revenue generated through consultation fees paid by patients visiting diagnostic centres.
4. Acquisition Revenue: Strategic acquisitions of diagnostic providers to expand service offerings and geographic reach, generating revenue through integration of acquired operations into the Suraksha network.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels4 records

Core offering

Suraksha Diagnostics operates an integrated diagnostic services platform delivering pathology, radiology/imaging, genomics, cardiology, neurology, and gastroenterology diagnostics through 70+ owned and franchisee centres plus government hospital PPP arrangements across eastern and north-eastern India. The company monetizes through per-test fees, bundled health checkup packages, specialist polyclinic consultations, home sample collection, and online doctor consultations. Established services are augmented with AI-driven imaging and modern genomic testing technologies including NIPT and NGS.

Product overview

Suraksha Diagnostics operates as an integrated diagnostic platform offering a comprehensive one-stop solution for pathology, radiology, and medical consultation services under one roof. Established in 1992, the company provides pathology testing (Microbiology, Serology, Molecular Biology, Histopathology, Cytopathology, Haematology, Clinical Biochemistry, Immunohistochemistry, FISH, Cytogenetics, Flow Cytometry, Newborn Screening, NGS), advanced radiology/imaging (X-Ray, AI-enabled MRI, CT Scan, 4D Ultrasound, DEXA Scan, Mammography, OPG), genomics services (Microarray, NIPT, QF-PCR, FISH, Karyotyping), and specialist polyclinic consultations. The platform integrates these core diagnostic services with value-added offerings including home sample collection, online doctor consultations, home doctor visits, and over 50 health checkup packages ranging from basic screenings to comprehensive full-body checkups. The company also operates Public-Private Partnership (PPP) centers at government hospitals and maintains a strong presence across eastern and north-eastern India through its extensive network of diagnostic centers.

Differentiator

Problem solved

Functional benefit

Products and services

• Pathology Services Comprehensive pathology testing covering Microbiology, Serology, Molecular Biology, Histopathology, Cytopathology, Clinical Pathology, Haematology, Clinical Biochemistry & Immunology, Immunohistochemistry, FISH, Cytogenetics, Flow Cytometry, Newborn Screening (LC-MS/MS), and Next Generation Sequencing (NGS). Available to individual patients, corporate clients, and government hospital patients across eastern India.
• Radiology and Imaging Services Advanced radiology and imaging including X-Ray, AI-enabled MRI Scan, 128-slice cardiac CT Scan, 4D Ultrasound, DEXA Scan for bone density, Mammography, and OPG dental imaging. AI integration across X-ray, CT, MRI, and PET imaging enhances disease detection and improves cancer screening accuracy.
• Genomics Services Specialized genetic testing including Microarray, Non-Invasive Prenatal Testing (NIPT), QF-PCR, FISH, Karyotyping, and Next Generation Sequencing for prenatal, postnatal, and preimplantation genetic testing. Targeted at expectant mothers, couples, and patients seeking advanced reproductive and hereditary diagnostics.
• Cardiology Diagnostics Cardiac diagnostic services including ECG, Echocardiogram (Echo), Stress Test/Treadmill Test (TMT), Wireless Holter Monitoring, and Pulmonary Function Test (PFT). For patients with suspected cardiac conditions or undergoing preventive cardiac screening.
• Neurology Diagnostics Neurological diagnostic testing including EEG (Electroencephalography), EMG (Electromyography), and NCV (Nerve Conduction Velocity) studies. Used for evaluation of epilepsy, neuromuscular disorders, and nerve-related conditions.
• Gastroenterology Diagnostics Gastrointestinal endoscopic procedures including Upper GI Endoscopy (High Definition), Lower GI Endoscopy, Sigmoidoscopy, Proctoscopy, Colonoscopy, and Proctosigmoidoscopy. Performed by specialist gastroenterologists at Suraksha centres.
• Suraksha Polyclinics - Specialist Consultations Neighbourhood polyclinics offering specialist doctor consultations across general physicians, pediatricians, gynecologists, surgeons, cardiologists, neurologists, and super-specialists such as rheumatologists, oncologists, hematologists, and nephrologists. Consultation fees range from ₹500 to ₹1,500 depending on specialist.
• Home Sample Collection Service Doorstep sample collection service allowing patients to provide blood and other diagnostic samples from home or office, with online report delivery. Adds convenience for elderly, chronically ill, and time-constrained patients across eastern India.
• Online Doctor Consultation Virtual consultation service allowing patients to consult Suraksha-affiliated doctors remotely via the company's digital platform. Provides remote access to specialist advice without requiring a centre visit.
• Home Doctor Visit House call service providing doctor visits to patients' homes for consultation and medical care. Targeted at elderly, mobility-restricted, and chronically ill patients in Suraksha's service areas.
• Full-Body Health Checkup Packages Pre-defined bundled health screening packages including Suraksha Tax Saver Health Checkup, Comprehensive Health Check, Men Gold, Men Gold Plus, Women's Gold, Women Gold Plus, Senior Male, and Senior Female packages. Range from basic 50-test panels to 77-test comprehensive panels (e.g., ₹9,500 from ₹19,000 for Women Gold Plus). Designed for preventive screening with demographic targeting.
• At-Home Health Packages Home-deliverable health screening packages including Basic and Advanced Health Packages, age-specific 40 Plus and 60 Plus packages, Pre-Marriage Profiles, Immunity Panels, Vitamin Check, Heart Health, Liver and Kidney panels, Thyroid panels, Bone Care, Arthritis Panel, Infertility Panels, Hypertension and Diabetes panels, Anaemia panels, PCOS, Fever Panels, COVID packages, Rheumatology profiles, Thalassemia Profile, and APLA Profile.
• Specialty Clinic Services Specialty clinic services including Dental Clinic (root canal, dentures, crowns & bridges, pediatric dental care), Physiotherapy (injury rehabilitation, pain management, sports injuries, stroke management), ENT, Fetal Care, Eye Clinic, IVF, Sleep Therapy, Diabetic Clinic, Obesity Clinic, Psychological Counseling, Gastro Clinic, Old Age Clinic, Pain Clinic, Speech Therapy, Chiropractic, Vertigo Clinic, Derma Clinic, and Adult Vaccine services.

Quantifiable outcome

• 25.07% YoY revenue growth to ₹81.41 crore in Q4 FY26
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core and strategic.

• Fetomat WellnesscoreStrategic or Co-development Partner · 21 April 2026Suraksha Diagnostics acquired 63% stake in Fetomat Wellness for Rs 5.19 crore to expand maternal-fetal healthcare services in eastern India. The acquisition aims to incorporate Fetomat's specialized services into Suraksha's diagnostic network, utilizing modern genomic technology for enhanced prenatal and reproductive health services.
• Yourgene HealthstrategicStrategic or Co-development Partner · 10 October 2025International partner for genetic testing technologies. Yourgene Health experts participated in Suraksha's scientific session on 'Advances in Genetics & Reproductive Health', presenting on prenatal, postnatal, and preimplantation genetic testing technologies.
• Thermo Fisher ScientificstrategicStrategic or Co-development Partner · 10 October 2025International partner for reproductive health technologies. Thermo Fisher Scientific experts collaborated with Suraksha on a scientific session covering prenatal, postnatal, and preimplantation genetic testing technologies and their applications in Indian healthcare.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Dr. Lal PathLabs: India's largest listed diagnostic chain operating a hub-and-spoke pathology network with home collection. Directly comparable on core pathology and preventive health packages, and a benchmark Suraksha competes with for pan-India patient referrals.
• Metropolis Healthcare: Listed national diagnostics chain offering integrated pathology, radiology, and wellness packages across India. Closely mirrors Suraksha's integrated pathology-radiology model and B2C health-package revenue streams.
• Thyrocare Technologies: Listed diagnostics network (now under PharmEasy) known for low-cost preventive health packages and pan-India B2B franchise collection. Comparable on bundled health packages and franchise-led expansion model.
• Agilus Diagnostics (formerly SRL Diagnostics): Large national pathology and radiology chain owned by Manipal. Competes with Suraksha across routine pathology, imaging, and hospital B2B contracts.

Broad incumbents

• Apollo Diagnostics: Diagnostic arm of Apollo Hospitals, leveraging the parent hospital brand and patient flow. Overlaps with Suraksha's radiology, pathology, and preventive health offerings but operates as part of a much larger hospital group.

Emerging players

• Neuberg Diagnostics: Fast-growing pan-India diagnostics chain formed via regional lab consolidation with strong international (globally branded) lab partnerships. Comparable on integrated pathology-plus-radiology footprint and franchise-based geographic expansion.
• Healthians: Digital-first diagnostics player specialising in at-home sample collection and online booking across India. Direct overlap on home-collection convenience and preventive health packages, competing for the same retail customer.

Regional players

• Vijaya Diagnostic Centre: Leading diagnostic chain concentrated in Andhra Pradesh and Telangana. Comparable integrated pathology/radiology model and B2C health package strategy; relevant as a regional competitor archetype Suraksha may face outside its core geography.
• Suburban Diagnostics: Diagnostics chain with strong presence in Maharashtra and western India. Comparable integrated offerings (pathology + imaging + home collection) and similar mid-tier market positioning.

Others

• Tata 1mg (formerly 1mg): Digital health platform offering online diagnostics booking, e-pharmacy, and teleconsultation. Competes for the same patient funnel on online appointment and home-collection, and channels diagnostic demand to partner labs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/suraksha-diagnostics-pvt-ltd
• Facebookfacebook.com/SurakshaDiagnosticServices

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Suraksha Diagnostics